New antiarrhythmic drug in pediatric use: sotalol

Pediatric Cardiology
J P Pfammatter, T Paul

Abstract

Sotalol is a noncardioselective beta-blocking agent with additional class III antiarrhythmic properties (action potential duration prolongation). These combined electrophysiologic effects make it a valuable drug for treating various arrhythmias. Its effectiveness for suppressing supraventricular reentrant tachycardias in children is well documented. Atrial flutter in children can be effectively managed in a high percentage of those treated. Ventricular arrhythmias in children can be adequately controlled by the administration of oral sotalol. Side effects are those typically seen during the course of treatment with a beta-blocker and lead to discontinuation of the drug in 3-6% of children. Proarrhythmia is another concern after sotalol administration. Increased ventricular ectopy, impairment of atrioventricular conduction, and suppression of sinus node activity with exacerbation of bradycardia (especially in children with sinus node dysfunction) may be found in a considerable number of treated patients, usually within a few days of sotalol initiation. Sotalol is an effective antiarrhythmic drug, but its potential side effects warrant inpatient treatment initially and close electrocardiographic monitoring.

Citations

Aug 22, 2012·Current Treatment Options in Cardiovascular Medicine·Carolina EscuderoShubhayan Sanatani
Mar 19, 2004·The Journal of Emergency Medicine·Jeffrey N Love, Neal Sikka
Aug 30, 2005·Journal of Pharmacological and Toxicological Methods·Jan-Peer Elshoff, Stephanie Läer
Dec 12, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·A CelikerS Ozme
Jul 16, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Josep BrugadaUNKNOWN Association for European Paediatric and Congenital Cardiology
Jun 10, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Jean-Pierre PfammatterJürg Pfenninger
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·A S BatraM J Silka
Feb 13, 1999·Pediatric Cardiology·W Rokicki, M Dukalska
Sep 3, 2010·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·M C TaveraR Tumbarello
Sep 30, 2010·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Maria Cristina TaveraRoberto Tumbarello
Jun 18, 2009·Journal of Clinical Pharmacology·Stephanie LäerBernd Meibohm
Dec 16, 2005·Fetal Diagnosis and Therapy·Mandakini PradhanAditya Kapoor
Feb 8, 2003·Prenatal Diagnosis·Jean-Marie JouannicMarc Dommergues
Jun 14, 2000·Circulation·M A OudijkE J Meijboom
May 28, 2020·Pacing and Clinical Electrophysiology : PACE·Marko BjeloševičRobert Hatala
Oct 1, 2001·Paediatrics & Child Health·M Bellavance
Apr 25, 2020·JACC. Clinical Electrophysiology·Alejandro A BorquezJames C Perry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.